Serum Interferon (IFN)-Neutralizing Antibodies and Bioactivities of IFNs in Patients with Severe Type II Essential Mixed Cryoglobulinemia

The efficacy of alpha interferon (IFN-α) in the treatment of severe type II essential mixed cryoglobulinemia (EMC) has been reported previously. In some patients, the development of neutralizing antibodies to recombinant IFN-α (rIFN-α) can affect the clinical response achieved with rIFN-α; a second...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Scagnolari, Carolina, Casato, Milvia, Bellomi, Francesca, De Pisa, Francesca, Turriziani, Ombretta, Coviello, Rossella, Pirro, Maria Rosaria, Dianzani, Ferdinando, Antonelli, Guido
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2003
Schlagworte:
Experimental Clinical Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC145266/
https://ncbi.nlm.nih.gov/pubmed/12522042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CDLI.10.1.70-77.2003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge